Innovative Trials partners with Alzheimer’s ResearchUK to raise money for life-changing dementia research

Monday 5th July 2021

Alzheimer’s Research UK has been selected as the official 2021 charity partner of Hertfordshire-based company, Innovative Trials.

The company, which specialises in clinical trial patient recruitment and community engagement, is aiming to raise at least £5,000 for the charity over the next 12 months. The funds raised will support groundbreaking dementia research for a world free from the fear, harm, and heartbreak of dementia.

In the UK, almost one million people are thought to be living with dementia and this is expected to rise to two million by 2050. Alzheimer’s Research UK is the UK’s leading dementia research charity committed to developing life-changing treatments and cures – a mission shared by Innovative Trials.

Kate Shaw, founder and CEO of Innovative Trials, said: “Dementia is a devastating and cruel condition that slowly strips people of their identities and, ultimately, their lives. Having worked with clients to recruit patients into clinical trials for potential Alzheimer’s treatments, our employees have seen for themselves the impact that dementia can have on patients and their families. The only way to make change is through research to better understand the causes, improve diagnosis and develop treatments and cures. Each and every member of staff at Innovative Trials feels passionately about supporting this noble cause, which is why we’ve committed to raising £5,000 for Alzheimer’s Research UK.”

Innovative Trials is currently finalising its fundraising calendar for the year ahead, which so far includes plans for a bake-off, firewalk, plank challenge, sports day and gaming marathon.



Sophie Griffiths, Corporate Partnerships Officer for Alzheimer’s Research UK, said: “We’re delighted that Innovative Trials has chosen Alzheimer’s Research UK as its charity partner. Sadly, dementia affects us all but thanks to companies like Innovative Trials, we’re able to take one step closer to making breakthroughs in dementia research possible. The support of clinical trials and studies provides a crucial lifeline to the progression of our research and will help to bring about life-changing treatments for people affected by the condition sooner.We can’t wait to work with Innovative Trials on some of the fantastic fundraising activities its staff has planned throughout the partnership!”

Innovative Trials is committed to supporting charitable causes and has previously raised £5,000 for Crohn’s and Colitis UK. Activities included raffles, a bake-off, the sale of unused office furniture and a virtual London to Brighton walk during lockdown.

Innovative Trials’ fundraising efforts support its overarching mission to enable all patients to have faster access to life-improving treatments.

About Innovative Trials

Founded in 2010, Innovative Trials works alongside pharmaceutical and clinical research organisations to ensure that patients enrol onto clinical trials in a timely manner and are fully informed of what the research will involve for themselves and their families. This enables potential new treatments to come to market as early as possible to provide alternative therapeutic options for present and future patients. Based in Letchworth Garden City in Hertfordshire, Innovative Trials employs around 64 members of staff in the UK. The company works internationally with a further 70 people stationed overseas in 70 countries to help clinical trial researchers recruit eligible patients and keep them involved.

About Alzheimer’s Research UK
● Alzheimer’s Research UK is the UK’s leading charity specialising in finding preventions,
treatments and a cure for dementia.
● For our latest updates follow us on Twitter @AlzResearchUK

● Our animation “What is dementia?” explains the essentials of dementia and the diseases
that cause it
● We rely on donations to fund our vital dementia research. To help make breakthroughs
possible, donate today by visiting or calling 0300 111 5555.
● We are currently supporting pioneering dementia research projects worth nearly £34 million
in leading Universities across the UK.
● How can we challenge perceptions of dementia using only an orange? Find out more at and help us share a better understanding about
dementia. #ShareTheOrange